A new technique developed at the Massachusetts Institute of Technology helps convert skin cells into neurons without needing ...

Dr. Dina Radenkovic, CEO of Gameto, discusses the key considerations for bringing iPSC-based fertility treatments to market from a regulatory and manufacturing perspective.

Dr. Dina Radenkovic, CEO of Gameto, discusses the use of iPSCs in fertility treatments, the most significant scientific hurdles they've encountered in developing and scaling these therapies ...

ACROBiosystems has developed novel hydrogel-free, human iPSC-derived, assay-ready cardiac and cerebral organoid systems, which are now commercially available. Cerebral and cardiac organoids each ...

PHILADELPHIA, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in ...

Century Therapeutics (NASDAQ:IPSC – Get Free Report) is anticipated to issue its quarterly earnings data before the market ...

A Phase III trial investigating a method of maturing human eggs outside of the body using induced pluripotent stem cells (iPSC) has been given the green light after the US Food and Drug ...

DUBLIN--(BUSINESS WIRE)--The "Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, & Forecasts, 2025" report has been added to ResearchAndMarkets.com's offering. Since the ...